GILL JOHN bought ALT
April 6, 2026 · Form 4 insider transaction
GILL JOHN bought 9,200 shares of Altimmune, Inc. at $3.41 per share, a transaction worth $31.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,200
Price
$3.41
Total value
$31.3K
InsiderGILL JOHN
RoleDirector
CompanyAltimmune, Inc. (ALT)
SecurityCommon Stock, par value $0.0001
Transaction codeP: Open-market purchase
Transaction dateApril 6, 2026
Filing dateApril 6, 2026
Shares owned after21,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4050 to $3.4080, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.